Arkolith/Insider Trading/HRTX/Form 4

Forbes William P

EVP, Chief Development OfficerHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Oct 21, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 19, 2025Option exercise(M)4K——155K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 19, 2025Option exercise(M)4K—$035K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-244582) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML